| TNYA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||
Below is a table of the TNYA market cap history going back to 9/2/2021:
Also see: TNYA Shares Outstanding History and TNYA YTD Return |
As of 7/30/2026 Tenaya Therapeutics has a market cap of 168.17 million. Investors often follow the TNYA market cap history to compare the size of the company over time.
This page shows TNYA market capitalization trends over time, with 19 market cap datapoints presented, dating back to 9/2/2021.

| TNYA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||
Below is a table of the TNYA market cap history going back to 9/2/2021:
Also see: TNYA Shares Outstanding History and TNYA YTD Return |
| TNYA Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||
TNYA Historical Market Cap: -29.78% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||
| TNYA Stock Price Chart |
| About Tenaya Therapeutics Inc |
| Tenaya Therapeutics, Inc. is a clinical-stage biotechnology company. Co. is focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. Co. is advancing a pipeline of novel therapies with diverse treatment modalities for rare genetic cardiovascular disorders and more prevalent heart conditions. Co.'s advanced product candidates include TN-201, TN-401, and TN-301. TN-201 is an adeno-associated virus serotype 9 (AAV9)-based gene therapy being developed to treat the underlying cause of MYBPC3 associated HCM by delivering a working MYBPC3 gene to specific cells of the heart via a single infusion. We show 19 historical shares outstanding datapoints in our TNYA shares outstanding history coverage, used to compute TNYA market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing TNYA market cap history over the course of time is important for investors interested in comparing TNYA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of TNYA versus a peer is one thing; comparing TNYA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like TNYA can fluctuate over the course of history. With this page we aim to empower investors researching TNYA by allowing them to research the TNYA market cap history. |
| TNYA Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| TNYA Share Performance |
| Market Cap Peers |
| Tenaya Therapeutics (TNYA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
TOCA Market Cap History TOI Market Cap History TORC Market Cap History TPIV Market Cap History TPST Market Cap History TPTX Market Cap History TRAW Market Cap History TRDA Market Cap History TRML Market Cap History TROV Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.